Posts by: Ana Pamplona, PhD

Researchers from Karolinska Institutet in Sweden and Nanyang Technological University in Singapore showed that the drug Imatinib, a tyrosine kinase inhibitor ... Read more

March 23, 2015March 23, 2015

Genetic Variants Determine Aspirin and NSAIDs Benefits in Colon Cancer Risk

In a recent study entitled “Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants,” published in ... Read more

March 19, 2015March 19, 2015

MSI2 RNA-binding Protein the New “kid on the block” in Colon Cancer

A new study on Colon Cancer revealed a novel player in the development of the disease, a RNA-binding protein Musashi homolog ... Read more

March 18, 2015March 18, 2015

Study Highlights Long-term Survival Rates for Invasive Cancers Such as Colon Cancer

The Morbidity and Mortality Weekly Report recently included a study from Centers for Disease Control and Prevention (CDC) entitled “Invasive Cancer ... Read more

September 24, 2014September 24, 2014

Researchers Uncover Cancer Drug Target That Utilizes Lipid Chemical Messengers

A new study, entitled “TIPE3 Is the Transfer Protein of Lipid Second Messengers that Promote Cancer” published on Cancer Cell by first ... Read more

Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Imatinib Inhibits EphB Abl Signaling Pathway and Suppresses Colorectal Cancer

Genetic Variants Determine Aspirin and NSAIDs Benefits in Colon Cancer Risk

MSI2 RNA-binding Protein the New “kid on the block” in Colon Cancer

Study Highlights Long-term Survival Rates for Invasive Cancers Such as Colon Cancer

Researchers Uncover Cancer Drug Target That Utilizes Lipid Chemical Messengers

Pin It on Pinterest